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Is there correlation between cognition and
functionality in severe dementia? The value of
a performance-based ecological assessment
for Alzheimer’s disease
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ABSTRACT
Objective: Besides significant cognitive decline, patients in later stages of Alzheimer’s disease (AD) also present global functional
impairment, usually reported by their caregivers. This study searched for preserved activities of daily living by investigating correlations
among specific instruments for severe dementia with a performance-based functional scale. Method: A sample of 95 moderate to severe
AD patients and their caregivers underwent a neuropsychological battery consisting of screening tools, the Functional Assessment Staging
Test (FAST), the Severe Mini-Mental State Examination (MMSEsev) and a performance-based ecological scale, the Performance Test of
Activities of Daily Living (PADL). Results: Consistent findings emerged from the comparisons among tests. PADL showed significant
statistical correlation with MMSEsev (r,0.001), according to FAST subdivisions. Conclusion: Upon suspicion of unreliable caregiver
reports, ecological scales may be useful for disease staging. Variable degrees of functionality and cognition may be present even in later
stages of AD, requiring proper assessment.
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RESUMO
Objetivo: Além do significativo declínio cognitivo, pacientes em estágios avançados da doença de Alzheimer (DA) também apresentam
prejuízo funcional global. Este estudo investigou atividades de vida diária correlacionando teste específico para a demência grave, com
escala funcional baseada no desempenho.Método: 95 pacientes com DA foram submetidos a uma bateria neuropsicológica composta por
instrumentos de rastreio, a escala Functional Assessment Staging Test (FAST), o Mini-exame do Estado Mental grave (MEEMg) e escala
ecológica baseada no desempenho: a Performance Test of Activities of Daily Living (PADL). Resultados: Achados consistentes emergiram
da comparação entre os instrumentos. De acordo com as subdivisões da escala FAST, a PADL apresentou significativa correlação
estatística com o MEEMg (r,0.001). Conclusão: Na suspeita de relato pouco confiável por parte do cuidador, escalas ecológicas podem
ser úteis no estadiamento da doença. Igualmente à cognição, variados graus de funcionalidade estão presentes mesmo em fases
avançadas da DA, exigindo avaliação adequada.
Palavras-chave: doença de Alzheimer, neuropsicologia, atividades de vida diária.
Dementias are a worldwide burden to public health sys-
tems. Given the demographic changes with a global aging
trend ( faster in developing countries), estimates on the ris-
ing prevalence of these disorders are discouraging, consider-
ing associated costs in primary, secondary and tertiary levels
of care1. As suggested by current guidelines2, the progressive
course of dementia might be classified in three main stages:
mild – there is still some aptitude for independent life, des-
pite the impact on instrumental activities of daily living;
moderate – the abilities for independent living are limited
and supervision is needed in many activities; severe –
restricted independence for all activities, including personal
hygiene, limited language skills, sometimes with mutism,
and often apathy.
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Along the progression of Alzheimer disease (AD), even
basic activities and social interaction become increasingly
impaired3,4. Concerning executive functions, for instance, a
progressive deficit that also makes evaluation of cognitive
functions more difficult may be present5. There is some
skepticism in evaluating cognition and functionality in
severe stages of dementia. Furthermore, the nature of the
relationship between real life activities of daily living
(ADLs) and neuropsychological performance has yet to be
fully delineated. For this purpose, some studies have used
informant-based measures to assess functional status6, but
only a few used a performance-based measure, in which
the patient is actually observed and objectively rated on
his or her ability to perform various ADLs7; yet, no such
study has ever been conducted with moderate, moderately
severe, and severe AD patients.
In view of the scarcity of specific instruments that pre-
cisely evaluate cognitive and (performance-based) functional
abilities of these persons, the main objective of the present
study was to search for preserved activities of daily living
by investigating correlations among specific instruments
for severe dementia with a performance-based functional
scale, proposing a short and accessible neuropsychological
battery for public health care services.
METHOD
Sample
For this research, 95 male and female subjects with mod-
erate, moderately severe and severe AD and their caregivers
were consecutively included between December 2008
and January 2012. All subjects were followed by a multidisci-
plinary team consisting of three clinical neurologists, a
neuropsychologist and a speech therapist at the Behavioral
Neurology Outpatients Clinic of Hospital Sao Paulo,
Federal University of Sao Paulo. All patients met
Diagnostic and Statistical Manual of Mental Disorders -
DSM-IV2 diagnostic criteria for probable AD. For inclusion
in the study protocol, each patient should score between five
and fifteen points (5-15) on the traditional Mini-Mental State
Examination – MMSE8, and be on stages 2.0 or 3.0 of the
Clinical Dementia Rating scale – CDR9.
We excluded patients who did not spend time with the
same caregiver at least four daily hours for at least four days
per week, patients who had any uncorrected visual or auditory
deficits that could affect their evaluation (inadequate or
unsuited prostheses), and patients with history of cerebrovas-
cular diseases (ischemic or hemorrhagic strokes) in the
12 months preceding the neuropsychological assessment.
This study was approved by the Ethics Committee of
the Federal University of Sao Paulo (Registration 1373/09).
An Informed Consent was read to all subjects and their
caregivers before they signed it, and doubts were discussed
at any time during the study.
Instruments and Procedure
Regarding screening for cognition, we employed the
MMSE8 and, for an accurate stratification of disease staging,
the Functional Assessment Staging Test – FAST10 (a rating
scale comprising cognitive and functional items developed
for grading severe dementia).
For specific cognitive evaluation, we employed the Severe
Mini-Mental State Examination – MMSEsev11,12. The
MMSEsev is based on the original version of the MMSE8,
but with simpler questions, including self-recognition, ori-
entation, responding to simple commands, constructive
skills, semantic verbal fluency, and memory. Scores range
from 0 to 30, like the original test, and the mean time for
application ranges from 5 to 10 minutes.
For comparisons of cognitive scales with functionality,
the Performance Test of Activities of Daily Living – PADL13
was employed. It was initially developed for self-care evalua-
tions at geriatric psychiatric patients. This scale assesses
objective behavioral skills by way of 16 elementary and
minor complex activities of daily life. It is a structured per-
formance test requiring patients to objectively demonstrate
their abilities for selected activities of daily living, such as fill-
ing a glass of water and drinking it, making a phone call,
shaving and applying makeup, among others. Observation
of the actual performance in a clinical setting requires com-
mon items like a glass, a box of tissue paper, a comb or hair
brush, a nail-file, a spoon, a wall clock, a telephone, paper
and pencil, demanding awareness of safety (e.g. turning a
light switch on and off). Scores range from 0 (not completely
done) and 1 (correctly done) to 9 (unable), and it takes
around 20 minutes to be completed. Thus, the PADL cate-
gorizes patients into different levels of functional independ-
ence by way of the administration of tasks related to basic
and instrumental activities of daily living. Most tasks include
the manipulation of props, which can be assembled into a
portable kit and administered in remote settings.
An interview to collect personal data was the first step of
the assessment followed by the application of screening
scales, and then the complete neuropsychological battery.
Whenever fatigue, anxiety or nervousness were noticed the
test was interrupted, the subject was reassured, and the test-
ing proceeded on only after the subject calmed down, con-
sidering the possibility of postponing the end of the
assessment for another visit. The assessment for each
patient took around one hour to be completed.
Statistical analysis
Initially, statistical analysis was conducted by way of
a descriptive statistic with mean, median and square devi-
ation for quantitative variables that were put in dispersion
846 Arq Neuropsiquiatr 2014;72(11):845-850
graphics and box plots. Furthermore, qualitative variables
were analyzed by way of absolute and relative frequency
calculations.
Inferential analyses were undertaken to confirm or refute
evidences raised by the descriptive analysis. Pearson’s inter-
valar and point estimation14,15 were performed to quantify
the linear relationship between a variable and a constant.
Results from the PADL and the MMSEsev were correlated
according to FAST stages using Kruskal-Wallis test and
ANOVA as a fixed factor.
For all conclusions obtained by inferential analysis, the
threshold of significance was set at r,0.05.
RESULTS
A total of 95 patients with advanced AD were included.
Among them, mean age was 74.7±6.2 years-old, mean
schooling was 4.2±1.5 years, mean disease duration was
7.3±1.7 years, and most patients were female (65.3%). The
mean MMSE score was 9.6±3.0, and 76.8% of the patients
were severely impaired (CDR=3.0). Mean PADL score was
9.6±3.2 (median 9.0), ranging from 5.0 (minimum) to 16.0
(maximum). Results can be seen in Table 1.
The inferential results demonstrated that the sample dis-
tribution between the three different categories of FAST
(moderate: 5, moderately severe: 6 and severe: 7) showed
particular patterns at MMSEsev final scores. When test
scores were compared with each other, individuals with
FAST in the moderate stage (stage 5) showed positive statist-
ical correlation (r=0.002). Individuals with FAST in the mod-
erately severe stage (stage 6), representing 54.7% of the total
sample, had a significant correlation with PADL, considering
the results obtained on MMSEsev (r,0.001). Once compar-
ing severe FAST patients (stage 7) with moderately severe
dementia, a significant statistical correlation was also veri-
fied between PADL and MMSEsev (r=0.002). Details of these
results are shown in Table 2.
Figure 1 presents the joint distribution of PADL and
MMSEsev scores. In this sense, in agreement with estimates
of the linear correlation coefficients of Pearson (r), we
observe a statistically significant correspondence between
PADL and the MMSEsev (R=0.322, r=0.001), suggesting that
the performance-based tool (PADL) is positively and signific-
antly correlated to the specific cognitive measure for severe
dementia (MMSEsev).
Results of the analysis of variance (ANOVA) within each
of the FAST subcategories were significant (r,0.001) with
regard to the ecological functional scale taken as the meas-
ure to be tested (PADL) and the specific cognitive test for
severe dementia (MMSEsev). Nevertheless, Figure 2 shows
a boxplot illustration of the convergent progression of
PADL scoring according to stratified FAST (5 to 7B), dem-
onstrating a linear decrease according to the evolution of
the disease, suggesting a statistical correlation between cog-
nitive and functional decline.
Table 1. Neuropsychological test results.
Neuropsychological test Test parameter or score n % or value
CDR 2.0 (moderate dementia stage) 22 23.2%
3.0 (severe dementia stage) 73 76.8%
FAST moderate (5) 16 16.8%
moderately severe (6) 52 54.7%
severe (7) 27 28.4%
FAST 5 16 16.8%
6A 21 22.1%
6B 15 15.8%
6C 16 16.8%
7A 15 15.8%
7B 12 12.6%
MMSE mean - 9.6
median - 10.0
minimum-maximum - 5.0-15.0
standard deviation - 3.0
MMSEsev mean - 20.7
median - 21.0
minimum-maximum - 12.0-30.0
standard deviation - 4.2
PADL mean - 9.6
median - 9.0
minimum-maximum - 5.0-16.0
standard deviation - 3.2
CDR: clinical dementia rating; FAST: functional assessment staging test); MMSE: mini-mental state examination; MMSEsev: severe mini-mental state
examination; PADL: performance activities of daily living.
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DISCUSSION
Our findings suggest a significant correlation between
ecological measure and the Severe Mini-Mental State
Examination for severely impaired AD patients and, to the best
of our knowledge, this is the first Brazilian and South American
study to ever investigate ADLs in later stages of AD from an
ecological perspective. Beyond that, this study sought to evalu-
ate the aspects of the PADL stratification combined with FAST
subdivisions. Briefly, it can be concluded that there was a
meaningful relationship among the PADL test results when
compared with the MMSEsev evidencing a related progression
with regard to the gradual evolution of the disease.
The main purpose for correlating cognitive tools (appro-
priately weighted by specifically developed instruments for
moderate and severe stages of dementia) with functional
scales, which were intentionally chosen for their psychomet-
ric structure is because CDR and FAST are considered
“static” (or categorical) scales, whereas in applying PADL,
objective aspects that simulate some tasks of everyday life that
the subject does in an ecological environment are evaluated.
Scientific studies employing specific tools for severe
dementia are scarce, especially in Latin America.
Considering the factors that could affect survival in AD,
there is no available instrument for prospectively monitoring
neuropsychological changes in later stages of this dementia
syndrome16. From a psychometric perspective, there is an
Table 2. Correlations between neuropsychological test
results and stratified Functional Assessment Staging Test
(FAST).
FAST PADL MMSEsev
5
N 16 16
mean 13.6 24.1
median 13.5 23.0
minimum-maximum 11.0-16.0 21.0-30.0
standard deviation 1.7 3.4
6A
N 21 21
mean 11.6 22.0
median 12.0 21.0
minimum-maximum 9.0-14.0 17.0-29.0
standard deviation 1.7 3.7
6B
N 15 15
mean 9.7 18.7
median 10.0 17.0
minimum-maximum 5.0-13.0 16.0-24.0
standard deviation 2.6 3.2
6C
N 16 16
mean 7.8 21.8
median 8.0 21.5
minimum-maximum 5.0-11.0 12.0-30.0
standard seviation 1.8 5.2
7A
N 15 15
mean 6.6 17.0
median 7.0 16.0
minimum-maximum 5.0-9.0 14.0-21.0
standard deviation 1.2 2.3
7B
N 12 12
mean 6.8 19.9
median 6.0 21.0
minimum-maximum 5.0-15.0 17.0-23.0
standard deviation 2.7 2.3
p ,0.001b ,0.001a
aKruskal-Wallis testand; bANOVA as a fixed factor. MMSE: mini-mental
state examination; PADL: performance activities of daily living; N: number.
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Figure 1. Joint distribution of PADL (performance activities of
daily living) and MMSEsev (severe Mini-Mental State
Examination) scores.
Figure 2. PADL (performance activities of daily living) boxplot
according to stratified FAST (functional assessment staging
test).
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usual rate of progression which is frequently measured by
one instrument exclusively through quantitative rating.
Nevertheless, most studies employ superficial screening tests
and rarely monitor functionality or qualitative aspects in
these patients17,18,19.
The results of this study may direct future developments
with regard to specific techniques to deal with moderately
and severely impaired AD patients. The performance-based
approach usually requires patients to perform the particular
activity under the observation of the examiner. Performance-
based assessments have the advantage of objectively assessing
functionality in a level that is required for daily living. In this
sense, studies have shown that performance-based measures
of functional status tend to be more strongly associated with
neuropsychological accomplishment than informant-based
functional measures20,21.
Strengths and limitations of this study need to be
described. Patients were recruited from a single center,
and while taking into account the complexity of objective
assessments of cognition in later dementia stages, results
may not be generalizable to all elderly Brazilians with
advanced AD. Additionally, in view of the lack of standar-
dized neuropsychological instruments for these patients, it
is understood that further studies should be conducted with
different samples using alternative measures, with the aim to
find the same correlations or new results through the
application of different statistical techniques.
Despite these limitations, the current research achieved
significant results in investigating preserved activities of
daily living (even some basic instrumental abilities) in
severely impaired patients. As a rule, functional measures
are not fully accurate to resemble the actual behavior of
patients in the real world. Likewise, there are also some
weaknesses associated with the use of performance-based
measures. Nonetheless, there is an important difference
between performing an activity proposed by a rater-facilita-
tor in an outpatient setting versus the spontaneous behavior
while performing some activities of daily living in the home
environment22.
Finally, once adopted as the instrument to be tested (or a
“gold standard” measure) for the present research, PADL
results presented here have shown an accurate correlation
with cognitive tests that are reliable in the neuropsycholo-
gical evaluation of patients in moderate and severe stages
of AD. In conclusion, the findings of this study suggest that
the ecological functional assessment is a well-grounded
alternative for objectively following and assessing the
functional status of AD patients, beyond the reporting of
caregiver. Thus, the incorporation and enforcement of
instruments such as the one we have proposed can be of
paramount importance for clinical and multidisciplinary
teams to better understand the symptoms in these stages
of the disease23, as well as to propose proper therapeutic
alternatives24.
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